Get started
MAX HEALTHCARE INS LTDMAX HEALTHCARE INS LTDMAX HEALTHCARE INS LTD

MAX HEALTHCARE INS LTD

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals

MAXHEALTH trade ideas

Max Healthcare Institute Ltd - Breakout Setup, Move is ON...#MAXHEALTH trading above Resistance of 991 Next Resistance is at 1392 Support is at 721 Here is previous chart: Chart is self explanatory. Levels of breakout, possible up-moves (where stock may find resistances) and support (close below which, setup will be invalidated) are clearly defined. Disclaimer: This is for demonstration and educational purpose only. This is not buying or selling recommendations. I am not SEBI registered. Please consult your financial advisor before taking any trade.
NSE:MAXHEALTHLong
by MandeepSinghKohli
MAXHEALTH - Price Observation & OverviewOverview & Observation: 1. Trendline trap. 2. Good volume breakout. 3. Strength in buying. 4. Broke recent ATH. Trade Plan: 1. Best entry was around 850. One more aggressive entry can be planned but the risk will be higher in that case. - Stay tuned for further insights, updates and trade safely! - If you liked the analysis, don't forget to leave a comment and boost the post. Happy trading! Disclaimer: This is NOT a buy/sell recommendation. This post is meant for learning purposes only. Please, do your due diligence before investing. Thanks & Regards, Anubrata Ray
NSE:MAXHEALTHLong
by SuperNova396
#MaxHealth is getting ready to heal the pain #SuperChartzKey Levels: Support: 830 Closing Basis Resistance: 900, 999, 1099 Key Drivers: Max Healthcare Institute Limited, India's second-largest hospital chain, offers a diverse array of healthcare services, including complex procedures like transplants, robotic surgeries, cardiac, neuro, orthopedic, and oncology surgeries. They have 17 facilities with a current capacity of ~3,530 beds, boasting a ~75% occupancy rate. Their Max Lab has 435+ partner-run CCs, 23 CoCCs, and ~170 PAS. Max@Home conducts 3,000+ daily billed transactions and has 14 specialized services. Max MyHealth, their digital platform, accounted for ~21% of H1FY24 revenues. They have significant strategic partnerships with Deakin University and Imperial College London, with ~1,000 high-index journal research publications in the last 5 years and 500 completed clinical research projects. Max recently acquired 550 bedded Sahara Hospital for ~Rs. 940 crs and aims to double its bed capacity with a planned brownfield expansion of ~2600 beds and potential to add 1,000 beds through land parcels. They plan to add beds in NCR as follows: FY24: 300 beds for Rs. 918 crs, FY25: 819 beds for Rs. 1592 crs, FY26: 1100 beds for Rs. 1377 crs, FY27: 521 beds for Rs. 552 crs, FY28: 1350 beds. The company has a significant market capitalization of ₹84,041 Cr, with its current stock price at ₹865, fluctuating between a high of ₹910 and a low of ₹412. Its price-to-earnings ratio (P/E) stands high at 79.5, indicating investor optimism. The book value per share is ₹80.7, and the dividend yield is 0.12%. It maintains healthy returns with ROCE at 15.0% and ROE at 16.1%. The operating profit margin (OPM) is robust at 27.9%. The company's EPS is ₹10.9, and it demonstrates strong performance compared to the industry with a return over three months at 39.4% and return over three years at 65.2%. The return on assets is 11.4%, showcasing efficient asset utilization. It generated significant sales of ₹5,198 Cr. The enterprise value is ₹82,910 Cr, with an EVEBITDA ratio of 51.0. The debt-to-equity ratio is low at 0.08, reflecting a healthy financial structure. Overall, the company exhibits strong financials, profitability, and market performance.
NSE:MAXHEALTHLong
by SuperChartz
MAXHEALTH - Ichimoku Breakout📈 Stock Name - Max Healthcare Institute Ltd 🌐 Ichimoku Cloud Setup: 1️⃣ Today's close is above the Conversion Line. 2️⃣ Future Kumo is Turning Bullish. 3️⃣ Chikou span is slanting upwards. All these parameters are shouting BULLISH at the Current Market Price and even more bullishness anticipated AFTER crossing 900. 🚨 Disclaimer: This is not a Buy or Sell recommendation. It's for educational purposes and a guiding light to learn trading in the market. #CloudTrading #IchimokuCloud #IchimokuFollowers #Ichimokuexpert Excited about this analysis? Share your thoughts in the comments below! 👍 Like, Share, and Subscribe for daily market insights! 🚀 #StockAnalysis #MarketWatch #TradingEducation #ichimoku
NSE:MAXHEALTHLong
by nikunjbhadja
Unveiling the Potential in MAXHEALTH's Current TrendWelcome, traders! Today, we're diving into a fascinating analysis of MAXHEALTH, a stock that's showing some intriguing movements on the charts. Understanding the Current Situation MAXHEALTH has been a topic of interest lately, especially as it comes down from its all-time high. Our focus will be on its behaviour around the 125 minute demand zone. We'll analyse its movement on different time frames to get a comprehensive view. Technical Analysis of MAXHEALTH On the the daily chart, MAXHEALTH displays a clear uptrend. Notably, the price is reacting from the 20-day Exponential Moving Average (EMA 20) and an uptrend line. This confluence of indicators suggests a strong bullish momentum. Furthermore, in the weekly chart, there are no significant supply zones overhead, indicating a relatively clear path for potential upward movements. The Power of Demand Zones In our 125 minute chart, we observe a robust demand zone. After this zone was established, MAXHEALTH broke its previous all-time high. The price has now returned to this demand zone and is showing positive reactions. Trading Strategy and Risk Management Considering the current scenario, planning a buy trade seems promising. Your stop loss (SL) should be placed just below the demand zone. As there are no immediate supply zones on the HTF, one could consider riding the rally, periodically trailing the stop loss. For those targeting specific gains, the first target could be the all-time high of MAXHEALTH. Please note that this analysis is for educational purposes only, and I am not a SEBI registered analyst.
NSE:MAXHEALTHLong
by AfnanTAjuddin